National Healthcare Corp. (NHC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NHC SEC filings page.
National Healthcare Corp. (NHC) reported $1.6B in revenue over the twelve months to Jun 30, 2026, up 6.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
National HealthCare is turning faster revenue growth into wider operating margins and stronger cash generation without increasing balance-sheet leverage.
From FY2024 to FY2025, operating margin widened from6.9% to8.5% , showing that additional revenue was reaching operations more efficiently. Over the same period, operating cash flow rose from$107M to$185M , linking the improved accounting performance to actual cash rather than merely reported earnings.
Debt fell from
FY2025 free cash flow reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of National Healthcare Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
National Healthcare Corp. has an operating margin of 8.5%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 60/100, indicating healthy but not exceptional operating efficiency. This is up from 6.9% the prior year.
National Healthcare Corp.'s revenue surged 16.1% year-over-year to $1.5B, reflecting rapid business expansion. This strong growth earns a score of 76/100.
National Healthcare Corp. carries a low D/E ratio of 0.03, meaning only $0.03 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.
National Healthcare Corp.'s current ratio of 1.82 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.
National Healthcare Corp. has a free cash flow margin of 9.8%, earning a moderate score of 60/100. The company generates positive cash flow after capital investments, but with room for improvement.
National Healthcare Corp.'s ROE of 11.2% shows moderate profitability relative to equity, earning a score of 60/100. This is up from 10.4% the prior year.
National Healthcare Corp. scores 6.95, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.6B) relative to total liabilities ($451.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
National Healthcare Corp. passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, National Healthcare Corp. generates $1.54 in operating cash flow ($185.1M OCF vs $120.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
National Healthcare Corp. earns $20.15 in operating income for every $1 of interest expense ($128.4M vs $6.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
National Healthcare Corp. generated $408.0M in revenue in Q2 2026. This represents an increase of 8.8% from the same quarter a year earlier. Against the prior quarter it is up 6.9%.
National Healthcare Corp.'s EBITDA was $60.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 33.3% from the same quarter a year earlier. Against the prior quarter it is up 37.0%.
National Healthcare Corp. reported $40.3M in net income in Q2 2026. This represents an increase of 70.0% from the same quarter a year earlier. Against the prior quarter it is up 12.4%.
National Healthcare Corp. earned $2.54 per diluted share (EPS) in Q2 2026. This represents an increase of 67.1% from the same quarter a year earlier. Against the prior quarter it is up 11.9%.
Cash & Balance Sheet
National Healthcare Corp. generated $30.7M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 41.6% from the same quarter a year earlier. Against the prior quarter it is down 41.9%.
National Healthcare Corp. held $39.2M in cash against $0 in long-term debt as of Q2 2026, with $236.1M of liabilities due within a year.
National Healthcare Corp. paid $0.67 per share in dividends in Q2 2026. This represents an increase of 4.7% from the same quarter a year earlier. Against the prior quarter it is up 4.7%.
Margins & Returns
National Healthcare Corp.'s operating margin was 12.0% in Q2 2026, reflecting core business profitability. This is up 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.5 percentage points.
National Healthcare Corp.'s net profit margin was 9.9% in Q2 2026, showing the share of revenue converted to profit. This is up 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.
National Healthcare Corp.'s ROE was 3.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Not reported for Q2 2026.
Capital Allocation
National Healthcare Corp. spent $7.2M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 55.3% from the same quarter a year earlier. Against the prior quarter it is down 55.6%.
National Healthcare Corp. invested $12.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 22.8% from the same quarter a year earlier. Against the prior quarter it is up 29.9%.
Not reported for Q2 2026.
NHC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $408.0M+8.8% | $381.8M+2.2% | $386.5M+4.6% | $382.7M+12.5% | $374.9M+24.7% | $373.7M+25.7% | $369.4M+22.7% | $340.2M+17.9% |
| SG&A Expenses | $8.7M-0.9% | $5.8M-11.9% | N/A | $6.3M-0.6% | $8.8M+22.1% | $6.6M+7.6% | N/A | $6.3M+11.1% |
| Operating Income | $48.9M+43.5% | $32.3M+4.8% | $33.1M+14.5% | $30.4M+33.3% | $34.1M+51.4% | $30.8M+96.3% | $28.9M+41.4% | $22.8M+75.0% |
| EBITDA | $60.1M+33.3% | $43.9M+5.1% | $44.9M+11.2% | $41.5M+24.3% | $45.1M+41.6% | $41.7M+59.0% | $40.4M+25.3% | $33.4M+44.2% |
| Interest Expense | $13K-99.3% | $269K-87.2% | $816K-65.2% | $1.5M-16.4% | $2.0M | $2.1M+4478.3% | $2.3M+4091.1% | $1.7M+2162.3% |
| Income Tax | $13.5M+67.3% | $8.7M-23.8% | $6.9M+24682.1% | $13.4M-12.6% | $8.1M-15.2% | $11.4M+20.8% | $28K-99.7% | $15.3M+292.5% |
| Net Income | $40.3M+70.0% | $35.9M+11.3% | $24.8M+308.6% | $39.2M-8.3% | $23.7M-11.6% | $32.2M+22.9% | $6.1M-78.6% | $42.8M+311.9% |
| EPS (Basic) | $2.58+68.6% | $2.31+10.5% | $1.61+312.8% | $2.53-9.0% | $1.53-12.1% | $2.09+22.2% | $0.39-78.9% | $2.78+308.8% |
| EPS (Diluted) | $2.54+67.1% | $2.27+9.7% | $1.57+313.2% | $2.50-8.4% | $1.52-12.1% | $2.07+22.5% | $0.38-79.3% | $2.73+301.5% |
| Diluted Shares (Avg) | 16M+1.7% | 16M+1.3% | N/A | 16M0.0% | 16M+0.3% | 16M+0.5% | N/A | 16M+2.2% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
NHC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.5B-1.6% | $1.5B-1.6% | $1.5B+0.1% | $1.6B+0.6% | $1.6B+16.6% | $1.5B+17.4% | $1.5B+16.3% | $1.6B+21.9% |
| Current Assets | $439.6M-5.1% | $465.6M+2.3% | $461.8M+8.8% | $493.5M+10.7% | $463.2M+3.4% | $455.2M+9.0% | $424.4M+4.5% | $445.7M+16.5% |
| Cash & Equivalents | $39.2M-64.7% | $85.5M-5.4% | $92.8M+21.9% | $130.6M+54.0% | $111.0M-18.5% | $90.4M-3.8% | $76.1M-28.9% | $84.8M-15.5% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $8.5M+8.2% | $9.2M+13.3% | $7.8M-13.8% | $7.8M+0.1% | $7.9M+19.0% | $8.1M+19.5% | $9.0M+22.4% | $7.8M+6.3% |
| Accounts Receivable | $137.7M-3.1% | $137.7M-2.8% | $139.0M+2.7% | $132.4M+2.8% | $142.1M+29.9% | $141.7M+12.8% | $135.3M+24.7% | $128.8M+25.5% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $170.5M0.0% | $170.5M0.0% | $170.5M0.0% | $170.5M+0.5% | $170.5M+1.3% | $170.5M+1.3% | $170.5M+1.3% | $169.7M+0.8% |
| Total Liabilities | $408.9M-23.8% | $427.5M-21.0% | $451.9M-16.5% | $513.9M-10.8% | $536.8M+37.0% | $540.8M+37.6% | $541.3M+35.2% | $575.9M+46.0% |
| Current Liabilities | $236.1M-12.1% | $250.8M+4.8% | $253.6M+8.0% | $282.4M+13.9% | $268.7M+23.9% | $239.2M+15.9% | $234.8M+9.5% | $247.9M+21.1% |
| Non-Current Liabilities | $172.8M-35.6% | $176.7M-41.4% | $198.3M-35.3% | $231.6M-29.4% | $268.1M+53.3% | $301.6M+61.6% | $306.5M+64.9% | $328.0M+72.7% |
| Long-Term Debt | $0-100.0% | $0-100.0% | $32.5M-74.9% | $65.6M-49.3% | $102.5M | $126.5M | $129.5M | $129.5M |
| Total Equity | $1.1B+9.8% | $1.1B+8.6% | $1.1B+9.0% | $1.1B+7.1% | $1.0B+8.0% | $1.0B+8.7% | $980.2M+7.9% | $983.5M+11.1% |
| Retained Earnings | $888.7M+12.7% | $858.9M+10.8% | $833.0M+10.7% | $818.1M+8.3% | $788.8M+9.2% | $775.0M+10.0% | $752.2M+9.4% | $755.5M+13.1% |
NHC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $43.3M-31.1% | $62.5M+59.3% | $16.8M+31.4% | $66.2M+93.5% | $62.8M+24.0% | $39.3M+307.0% | $12.8M-50.3% | $34.2M+5.9% |
| Depreciation & Amortization | $11.2M+1.4% | $11.6M+5.8% | $11.8M+2.9% | $11.2M+5.1% | $11.0M+18.0% | $11.0M+3.7% | $11.4M-2.8% | $10.6M+4.8% |
| Stock-Based Compensation | N/A | $1.3M+24.6% | N/A | N/A | N/A | $1.0M+29.5% | N/A | N/A |
| Capital Expenditures | $12.5M+22.8% | $9.6M+57.1% | $10.4M+27.5% | $9.7M+71.6% | $10.2M+30.3% | $6.1M+3.1% | $8.2M-5.2% | $5.7M-13.1% |
| Free Cash Flow | $30.7M-41.6% | $52.9M+59.7% | $6.4M+38.4% | $56.5M+97.9% | $52.6M+22.9% | $33.1M+797.3% | $4.6M-73.0% | $28.6M+10.7% |
| Investing Cash Flow | -$87.7M-462.7% | -$13.9M-89.6% | -$12.9M-11.1% | $2.0M+100.9% | -$15.6M-1193.3% | -$7.3M-203.2% | -$11.6M-14.3% | -$224.1M-4263.3% |
| Financing Cash Flow | -$9.7M+70.8% | -$54.5M-329.4% | -$43.2M-124.0% | -$47.0M-133.7% | -$33.0M-334.0% | -$12.7M-5.2% | -$19.3M-96.2% | $139.3M+1518.7% |
| Dividends Paid | $10.0M+5.9% | $9.9M+5.5% | $9.9M+5.4% | $9.9M+5.4% | $9.4M+3.8% | $9.4M+4.1% | $9.4M+4.2% | $9.4M+4.1% |
| Share Buybacks | $7.2M+55.3% | $16.3M+847.8% | $5.2M | $3.2M+51.5% | $4.7M+210.4% | $1.7M-82.6% | $0 | $2.1M |
NHC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.0%+2.9pp | 8.5%+0.2pp | 8.6%+0.7pp | 7.9%+1.2pp | 9.1%+1.6pp | 8.2%+3.0pp | 7.8%+1.0pp | 6.7%+2.2pp |
| Net Margin | 9.9%+3.6pp | 9.4%+0.8pp | 6.4%+4.8pp | 10.3%-2.3pp | 6.3%-2.6pp | 8.6%-0.2pp | 1.7%-7.8pp | 12.6%+9.0pp |
| Return on Equity | 3.6%+1.3pp | 3.3%+0.1pp | 2.3%+1.7pp | 3.7%-0.6pp | 2.3%-0.5pp | 3.2%+0.4pp | 0.6%-2.5pp | 4.3%+3.2pp |
| Return on Assets | 2.6%+1.1pp | 2.4%+0.3pp | 1.6%+1.2pp | 2.5%-0.2pp | 1.5%-0.5pp | 2.1%+0.1pp | 0.4%-1.8pp | 2.7%+1.9pp |
| Current Ratio | 1.86+0.1x | 1.860.0x | 1.820.0x | 1.750.0x | 1.72-0.3x | 1.90-0.1x | 1.81-0.1x | 1.80-0.1x |
| Debt-to-Equity | 0.00-0.1x | 0.00-0.1x | 0.03-0.1x | 0.06-0.1x | 0.10-0.3x | 0.13-0.3x | 0.13+0.1x | 0.13-0.3x |
| Asset Turnover | 0.270.0x | 0.250.0x | 0.250.0x | 0.240.0x | 0.240.0x | 0.240.0x | 0.240.0x | 0.220.0x |
| FCF Margin | 7.5%-6.5pp | 13.9%+5.0pp | 1.7%+0.4pp | 14.8%+6.4pp | 14.0%-0.2pp | 8.9%+7.6pp | 1.3%-4.4pp | 8.4%-0.5pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| National Healthcare Corp. NHC | FY2025 | $1.5B | $120.0M | 7.9% | $3.6B | 67/100 |
| Aveanna Healthcare Holdings Inc. AVAH | FY2026 | $2.4B | $225K | 0.0% | $2.7B | 36/100 |
| Brookdale Senior Living, Inc. BKD | FY2025 | $3.2B | -$262.7M | -8.2% | $2.6B | 25/100 |
| P3 Health Partners Inc. PIII | FY2025 | $1.5B | -$147.9M | -10.1% | $22.0M | 24/100 |
| PACS Group, Inc. PACS | FY2025 | $5.3B | $191.5M | 3.6% | $6.8B | 49/100 |
| Guardian Pharmacy Services, Inc. GRDN | FY2025 | $1.4B | $49.2M | 3.4% | $2.6B | 53/100 |
Where National Healthcare Corp. Ranks
Frequently Asked Questions
What is National Healthcare Corp.'s annual revenue?
National Healthcare Corp. (NHC) reported $1.5B in total revenue for fiscal year 2025. This represents a 16.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is National Healthcare Corp.'s revenue growing?
National Healthcare Corp. (NHC) revenue grew by 16.1% year-over-year, from $1.3B to $1.5B in fiscal year 2025.
Is National Healthcare Corp. profitable?
Yes, National Healthcare Corp. (NHC) reported a net income of $120.0M in fiscal year 2025, with a net profit margin of 7.9%.
What is National Healthcare Corp.'s EBITDA?
National Healthcare Corp. (NHC) had EBITDA of $173.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does National Healthcare Corp. have?
As of fiscal year 2025, National Healthcare Corp. (NHC) had $92.8M in cash and equivalents against $32.5M in long-term debt.
What is National Healthcare Corp.'s operating margin?
National Healthcare Corp. (NHC) had an operating margin of 8.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is National Healthcare Corp.'s net profit margin?
National Healthcare Corp. (NHC) had a net profit margin of 7.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does National Healthcare Corp. pay dividends?
Yes, National Healthcare Corp. (NHC) paid $2.53 per share in dividends during fiscal year 2025.
What is National Healthcare Corp.'s return on equity (ROE)?
National Healthcare Corp. (NHC) has a return on equity of 11.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is National Healthcare Corp.'s free cash flow?
National Healthcare Corp. (NHC) generated $148.6M in free cash flow during fiscal year 2025. This represents a 86.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is National Healthcare Corp.'s operating cash flow?
National Healthcare Corp. (NHC) generated $185.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are National Healthcare Corp.'s total assets?
National Healthcare Corp. (NHC) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are National Healthcare Corp.'s capital expenditures?
National Healthcare Corp. (NHC) invested $36.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is National Healthcare Corp.'s current ratio?
National Healthcare Corp. (NHC) had a current ratio of 1.82 as of fiscal year 2025, which is generally considered healthy.
What is National Healthcare Corp.'s debt-to-equity ratio?
National Healthcare Corp. (NHC) had a debt-to-equity ratio of 0.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is National Healthcare Corp.'s return on assets (ROA)?
National Healthcare Corp. (NHC) had a return on assets of 7.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is National Healthcare Corp.'s P/E ratio?
National Healthcare Corp. (NHC) trades at 25.5x earnings, its market capitalization divided by net income of $140.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.6B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is National Healthcare Corp.'s price-to-sales ratio?
National Healthcare Corp. (NHC) trades at 2.3x sales, its market capitalization divided by revenue of $1.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.6B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is National Healthcare Corp.'s Altman Z-Score?
National Healthcare Corp. (NHC) has an Altman Z-Score of 6.95, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is National Healthcare Corp.'s Piotroski F-Score?
National Healthcare Corp. (NHC) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are National Healthcare Corp.'s earnings high quality?
National Healthcare Corp. (NHC) has an earnings quality ratio of 1.54x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can National Healthcare Corp. cover its interest payments?
National Healthcare Corp. (NHC) has an interest coverage ratio of 20.15x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is National Healthcare Corp.?
National Healthcare Corp. (NHC) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.